99tcm-citrate a new bone imaging radiopharmaceutical

Nuclear Medicine Communications

Volumn 20, Issue 11, 1999, Pages 1067-1076

  Bhatnagar, Aseem ^a   Mishra, P ^a   Sharma, R ^a   Chuttani, K ^a   Chakravarty, K ^a   Jain, C M ^b   Mondal, A ^a   Chopra, M K ^a   Gupta, A ^a  

^a INSTITUTE OF NUCLEAR MEDICINE AND ALLIED SCIENCES   (India)

^b ESI HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CITRIC ACID; DIAGNOSTIC AGENT; MEDRONATE TECHNETIUM TC 99M; RADIOPHARMACEUTICAL AGENT; TECHNETIUM COMPLEX; TECHNETIUM DERIVATIVE; TECHNETIUM TC 99M CITRATE; TECHNETIUM TC 99M TIN COLLOID; TIN DERIVATIVE; TECHNETIUM 99M;

ADULT; ARTICLE; BONE; BONE DISEASE; BONE TUMOR; CLINICAL TRIAL; COMPARATIVE STUDY; DRUG STABILITY; FEMALE; HUMAN; MALE; METABOLISM; PH; SCINTISCANNING; TISSUE DISTRIBUTION; BONE ATROPHY; BONE MASS; BONE SCINTISCANNING; DIAGNOSTIC IMAGING; DRUG ACCUMULATION; DRUG UPTAKE; OSTEOBLAST; QUALITY CONTROL; TUMOR LOCALIZATION; WOUND HEALING;

ADULT; BONE AND BONES; BONE DISEASES; BONE NEOPLASMS; CITRATES; DRUG STABILITY; FEMALE; HUMANS; HYDROGEN-ION CONCENTRATION; MALE; ORGANOTECHNETIUM COMPOUNDS; RADIOPHARMACEUTICALS; TECHNETIUM COMPOUNDS; TECHNETIUM TC 99M MEDRONATE; TIN COMPOUNDS; TISSUE DISTRIBUTION;

EID: 0032586059     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1080/00006231-199911000-00013     Document Type: Article

References (13)

1. Haynie TP, Konikowski T, Glenn HJ et al. Technetium-99m stannous citrate brain tumour uptake in mice: A concise study. J Nucl Med 1977; 18: 915-918.
2. Gati LJ, Wiebe LI, Tse JW et al. Comparative studies of radiocitrates in oncological models. Nucl Med Biol 1986; 13: 253-255.
3. Ercan MT, Aras T, Aldahr AMS et al. Scintigraphic visual-ization of acute pancreatitis in cats with 99m-Tc citrate. Nucl Med Biol 1993; 14: 798-804.
4. Ercan MT, Aras T, Unlenen E et al. 99mTc citrate versus 67Ga citrate for the scintigraphic visualization of inflam-matory lesions. Nucl Med Biol 1993; 20: 881-887.
5. Cagler M, Tokgozoglu AM, Ercan MT et al. The value of Tc-99m citrate scintigraphy in chronic osteomyelitis: An indi-cator of the involved bone. Clin Nucl Med 1995; 20: 712-716.
6. Chauhan UPS, Mishra P, Chuttani K et al. A kit for the instant preparation of “Tcm-citrate for tumour and inflam-mation scintigraphy. Nucl Med Commun 1996; 17: 979-985.
7. Bhatnagar A, Sharma R, Mondal A et al. Tumour imaging using Tc-99m citrate. Ind J Nucl Med 1997; 12: 77-83.
8. Sharma R, Mondal A, Bhatnagar A et al. Differentiation of malignant and degenerative benign bone disease using 99mTc-MDP and 99mTc-citrate scintigraphy (in press).
9. Warwick R, Williams PL, eds. Gray’s anatomy, 35th edn. Edinburgh: Longman, 1973.
10. Munze R, Hoffmann I, Grossman B et al. Technetium che-lates with hydrocarboxylic acid ligands: Differences between 99mTc (millimolar) and 99mTc (nanomolar) con-centration level. In: Deutsch E, Nicolini M, Wagner HN, eds. Technetium in chemistry and nuclear medicine. Ver-ona: Cortina International, 1983: 51-55.
11. Watt I. Musculoskeletal system. In: Davies ER, Thomas WEG, eds. Nuclear medicine: Applications to surgery. Kent: Castle House, 1988: 219-253.
12. Mettler FA, Monsein I, Rosenberg RD. Radionuclides and normal bone scan. In: Mettler FA, ed. Radionuclide bone imaging and densitometry. New York: Churchill Living-stone, 1988: 13-29.
13. Bhatnagar A, Mondal A, Kashyap R et al. Differentiation of malignant and degenerative bone lesions using dexame-thason interventional 3-and 24-hour bone scintigraphy. Eur J Nucl Med 1994; 21: 609-614.